Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)

5.39
Delayed Data
As of Feb 27
 +0.06 / +1.13%
Today’s Change
3.11
Today|||52-Week Range
6.28
+33.75%
Year-to-Date
No recent news for Tetraphase Pharmaceuticals Inc.

Today’s Trading

Previous close5.33
Today’s open5.33
Day’s range5.31 - 5.44
Volume306,385
Average volume (3 months)384,373
Market cap$244.6M
Dividend yield--
Data as of 3:59pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)+5.22%
Earnings growth (this year)+16.95%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+28.45%
P/E ratioNM
Price/Sales30.26
Price/Book0.96

Competitors

 Today’s
change
Today’s
% change
MNKDMannKind Corp+0.01+1.69%
IDRAIdera Pharmaceutical...-0.02-1.20%
PETXAratana Therapeutics...+0.30+4.58%
CMRXChimerix Inc+0.21+3.85%
Data as of 4:00pm ET, 02/27/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$11.7M
Annual profit (last year)-$83.2M
Net profit margin-711.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO &
Class II Director
Guy MacDonald
Senior Vice President-
Finance
Christopher Watt
Corporate headquarters
Watertown, Massachusetts

Forecasts


Search for Jobs